Theralase Technologies Inc. (TLT) — Cash Flow Reinvestment Rate

Latest as of September 2018: 0.05x

Theralase Technologies Inc. (TLT) has a Cash Flow Reinvestment Rate of 0.05x as of September 2018, reinvesting CA$19.98K (capex CA$19.98K ) from operating cash flow of CA$436.21K. Check TLT operating cash flow to net income to evaluate the quality of earnings relative to operating cash generation.

Reinvestment Rate

0.05x
(Capex + Investments) / Operating CF

Total Reinvested

CA$19.98K
Capex + Investments

Operating Cash Flow

CA$436.21K
CAD

Capital Expenditures

CA$19.98K
CAD

Theralase Technologies Inc. Cash Flow Reinvestment Rate (2005–2005)

Historical reinvestment intensity for Theralase Technologies Inc. across 1 annual periods. Explore how well can Theralase Technologies Inc. service its debt to assess how comfortably operating cash covers total debt obligations.

Annual Cash Flow Reinvestment Rate for Theralase Technologies Inc. (2005–2005)

Year-by-year capital reinvestment analysis for Theralase Technologies Inc.. For live market cap and broader valuation context, see TLT market cap.

Year Reinvestment Rate Total Reinvested (CAD) Operating CF Capex YoY Change
2005 1.00x CA$85.30K CA$85.33K CA$85.30K —
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow